Results 131 to 140 of about 81,008 (204)

A Phase 2 Trial of RANKL Antibody, Denosumab, in Two Cohorts of Patients with Recurrent/Refractory Osteosarcoma, a Report from the Children's Oncology Group. [PDF]

open access: yesClin Cancer Res
Janeway KA   +16 more
europepmc   +1 more source

Lipocalin-2 upregulation in hypoxic murine osteocytes enhances RANKL-induced osteoclastogenesis. [PDF]

open access: yesSci Rep
Narita K   +8 more
europepmc   +1 more source

Effects of swimming on bone loss and mechanisms in ovariectomized osteoporotic rats. [PDF]

open access: yesOpen Med (Wars)
Zhao Y   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy